0.8449  0.049 (6.09%)		09-15 16:00
Open: 0.82 High: 0.888 Volume: 613,720		Pre. Close: 0.7964 Low: 0.8 Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	1.43	1-year :	1.81
Resists	First :	1.22	Second :	1.54
Pivot price	0.82
Supports	First :	0.7	Second :	0.59
MAs	MA(5) :	0.79	MA(20) :	0.9
	MA(100) :	11.89	MA(250) :	53.13
MACD	MACD :	-0.4	Signal :	-0.6
%K %D	K(14,3) :	21.6	D(3) :	16.5
RSI	RSI(14): 33.6
52-week	High :	172.89	Low :	0.7

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ NUWE ] has closed below upper band by 45.2%. Bollinger Bands are 95.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 58 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.89 - 0.89	0.89 - 0.9
Low:	0.79 - 0.8	0.8 - 0.8
Close:	0.84 - 0.84	0.84 - 0.85

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Thu, 27 Aug 2026
Nuwellis, Inc. SEC Filing (Aug 27, 2026) - Stock Titan

Tue, 25 Aug 2026
After a six-month pilot, Nuwellis may distribute a heart device across much of the U.S. - Stock Titan

Sat, 22 Aug 2026
NUWE Should I Buy - Intellectia AI

Tue, 04 Aug 2026
NUWE Stock Whipsaws As Growth, Patents And Volatility Collide - StocksToTrade

Fri, 31 Jul 2026
NUWE Stock Whipsaws As Traders Target Volatile Move - StocksToTrade

Thu, 30 Jul 2026
Nuwellis Inc. (NASDAQ: NUWE) Surges on Pediatric Cardiorenal Expansion as Oversold Stocks Take Center Stage – See Inside - Barchart.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	3 (M)
Held by Insiders	3.45e+006 (%)
Held by Institutions	6.1 (%)
Shares Short	114 (K)
Shares Short P.Month	0 (K)

EPS	2
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	-125.7 %
Operating Margin	-161 %
Return on Assets (ttm)	-87.9 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	14.1 %
Gross Profit (p.s.)	2.73043e+007
Sales Per Share	3.91739e+007
EBITDA (p.s.)	-5.53043e+007
Qtrly Earnings Growth	548.3 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-12 (M)

PE Ratio	0.42
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	-0.06

Dividend	0
Forward Dividend	90590
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.